Alessia D’Alonzo

562 total citations
23 papers, 341 citations indexed

About

Alessia D’Alonzo is a scholar working on Oncology, Public Health, Environmental and Occupational Health and Cancer Research. According to data from OpenAlex, Alessia D’Alonzo has authored 23 papers receiving a total of 341 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 7 papers in Public Health, Environmental and Occupational Health and 7 papers in Cancer Research. Recurrent topics in Alessia D’Alonzo's work include Reproductive Biology and Fertility (6 papers), Breast Cancer Treatment Studies (6 papers) and HER2/EGFR in Cancer Research (4 papers). Alessia D’Alonzo is often cited by papers focused on Reproductive Biology and Fertility (6 papers), Breast Cancer Treatment Studies (6 papers) and HER2/EGFR in Cancer Research (4 papers). Alessia D’Alonzo collaborates with scholars based in Italy, Belgium and United Kingdom. Alessia D’Alonzo's co-authors include Lucia Del Mastro, Francesca Poggio, Matteo Lambertini, Claudia Bighin, Alessia Levaggi, S. Giraudi, P. Pronzato, Marcello Ceppi, Paolo Bruzzi and Isabelle Demeestere and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Oncotarget.

In The Last Decade

Alessia D’Alonzo

20 papers receiving 335 citations

Peers

Alessia D’Alonzo
Alessia D’Alonzo
Citations per year, relative to Alessia D’Alonzo Alessia D’Alonzo (= 1×) peers Luca Arecco

Countries citing papers authored by Alessia D’Alonzo

Since Specialization
Citations

This map shows the geographic impact of Alessia D’Alonzo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alessia D’Alonzo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alessia D’Alonzo more than expected).

Fields of papers citing papers by Alessia D’Alonzo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alessia D’Alonzo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alessia D’Alonzo. The network helps show where Alessia D’Alonzo may publish in the future.

Co-authorship network of co-authors of Alessia D’Alonzo

This figure shows the co-authorship network connecting the top 25 collaborators of Alessia D’Alonzo. A scholar is included among the top collaborators of Alessia D’Alonzo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alessia D’Alonzo. Alessia D’Alonzo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
D’Alonzo, Alessia, et al.. (2025). First Documented Outbreaks of Lactococcus garvieae in Gilthead sea bream ( Sparus aurata ) in the Gulf of Follonica, Tuscany, Italy. Bulletin of the European Association of Fish Pathologists. 45(3).
2.
Battistuzzi, Linda, Eva Blondeaux, Francesca Poggio, et al.. (2024). Patterns of care at the end of life: a retrospective study of Italian patients with advanced breast cancer. BMC Palliative Care. 23(1). 129–129.
3.
Nardini, Roberto, et al.. (2019). Performance and trends of the results of the Interlaboratory Trials held between 2002-2017 for the serological tests employed for the diagnosis of Equine Infectious Anemia. Large animals review. 25(4). 141–145. 2 indexed citations
4.
Martinello, Rossella, Patrizia Vici, Mario Airoldi, et al.. (2019). Trastuzumab‐related cardiotoxicity in patients with nonlimiting cardiac comorbidity. The Breast Journal. 25(3). 444–449. 4 indexed citations
5.
Mustacchi, Giorgio, P. Pronzato, Grazia Arpino, et al.. (2019). Triple-negative (TNBC) metastatic breast cancer (MBC) patients (pts): Is chemotherapy (CHT) choice influenced by adjuvant (adj) treatments? Results from the GIM-13 AMBRA study.. Journal of Clinical Oncology. 37(15_suppl). e12549–e12549. 2 indexed citations
7.
Poggio, Francesca, Matteo Lambertini, Claudia Bighin, et al.. (2018). Management of young women with early breast cancer. ESMO Open. 3(Suppl 1). e000458–e000458. 16 indexed citations
8.
Cazzaniga, Marina Elena, P. Pronzato, Icro Meattini, et al.. (2018). Validation of time to treatment change (TTC) as a surrogate end-point of progression free survival (PFS) for observational trials in metastatic breast cancer patients (MBC): The GIM-13 AMBRA study.. Journal of Clinical Oncology. 36(15_suppl). e13081–e13081. 2 indexed citations
10.
Lambertini, Matteo, Paola Anserini, Valeria Fontana, et al.. (2017). The PREgnancy and FERtility (PREFER) study: an Italian multicenter prospective cohort study on fertility preservation and pregnancy issues in young breast cancer patients. BMC Cancer. 17(1). 346–346. 30 indexed citations
11.
Martinello, Rossella, Patrizia Vici, Mario Airoldi, et al.. (2017). Trastuzumab-related cardiotoxicity in patients with non-limiting cardiac comorbidity.. Journal of Clinical Oncology. 35(15_suppl). e12043–e12043.
12.
Blondeaux, Eva, Paolo Bruzzi, Matteo Lambertini, et al.. (2016). Treatment with aromatase inhibitors and markers of cardiovascular disease. Breast Cancer Research and Treatment. 160(2). 261–267. 5 indexed citations
13.
Boero, Silvia, Anna Morabito, Barbara Banelli, et al.. (2015). Analysis of in vitro ADCC and clinical response to trastuzumab: possible relevance of FcγRIIIA/FcγRIIA gene polymorphisms and HER-2 expression levels on breast cancer cell lines. Journal of Translational Medicine. 13(1). 24–24. 35 indexed citations
14.
D’Alonzo, Alessia, et al.. (2014). Monitoring of foodborne pathogens in raw cow milk in Tuscany. Italian Journal of Food Safety. 3(1). 1715–1715. 2 indexed citations
15.
Levaggi, Alessia, Andrea De Maria, Béatrice Dozin, et al.. (2014). Incidence of hepatitis in patients with evidence of past or current hepatitis B or C during chemotherapy for early breast cancer.. PubMed. 34(7). 3715–20. 2 indexed citations
16.
Mastro, Lucia Del, Marcello Ceppi, Francesca Poggio, et al.. (2013). Gonadotropin-releasing hormone analogues for the prevention of chemotherapy-induced premature ovarian failure in cancer women: Systematic review and meta-analysis of randomized trials. Cancer Treatment Reviews. 40(5). 675–683. 127 indexed citations
17.
Mastro, Lucia Del, Matteo Lambertini, Claudia Bighin, et al.. (2012). Trastuzumab as first-line therapy in HER2-positive metastatic breast cancer patients. Expert Review of Anticancer Therapy. 12(11). 1391–1405. 19 indexed citations
18.
Meszaros, Paolo, M. Guenzi, Renzo Corvò, et al.. (2011). Preliminary Experience Using Oncoplastic Techniques of Reduction Mammaplasty and Intraoperative Radiotherapy: Report of 2 Cases. Aesthetic Plastic Surgery. 35(6). 1180–1183. 3 indexed citations
19.
Corvò, Renzo, Francesco Ricchetti, S. Agostinelli, et al.. (2010). Adjuvant hypofractionated radiotherapy with weekly concomitant boost for women with early breast cancer: the clinical experience at Genoa university.. PubMed. 30(11). 4749–53. 20 indexed citations
20.
Guenzi, M., Stefano Vagge, Alessia D’Alonzo, et al.. (2010). A biologically competitive 21 days hypofractionation scheme with weekly concomitant boost in breast cancer radiotherapy feasibility acute sub-acute and short term late effects. Radiation Oncology. 5(1). 111–111. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026